Acceleron signs pulmonary research and discovery deal with Fulcrum Therapeutics

Acceleron Pharma has entered into a pulmonary research and discovery collaboration agreement with Fulcrum Therapeutics.

As part of the collaboration and licence agreement, the companies will work together to detect small molecules designed to modulate specific pathways linked with a targeted indication within the pulmonary disease space.